Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes.
The occurrence of neutrophils at the pannus-cartilage border is an important phenomenon for understanding the pathogenesis of rheumatoid arthritis (RA). Matrix metalloproteinases (MMPs) are predominant enzymes responsible for the cartilage degradation. The present article studied the expression of CD147 on neutrophils and its potential role in neutrophil chemotaxis, MMPs production and the invasiveness of fibroblast-like synoviocytes (FLS). The results of flow cytometry revealed that the mean fluorescence intensity of CD147 expression on neutrophils of peripheral blood from RA patients was higher than that in healthy individual. The potential role of CD147 in cyclophilin A (CyPA)-mediated cell migration was studied using chemotaxis assay and it was found that the addition of anti-CD147 antibody significantly decreased the chemotactic index of the neutrophils. Significantly elevated release and activation of MMPs were seen in the co-culture of neutrophil and FLS compared with cultures of the cells alone. An increased number of cells invading through the filters in the invasion assays were also observed in the co-cultured cells. The addition of anti-CD147 antibody had some inhibitory effect, not only on MMP production but also on cell invasion in the co-culture model. Our study demonstrates that the increased expression of CD147 on neutrophils in RA may be responsible for CyPA-mediated neutrophil migration into the joints, elevated MMPs secretion and cell invasion of synoviocytes, all of which may contribute to the cartilage invasion and bone destruction of RA. Better knowledge of these findings will hopefully provide a new insight into the pathogenesis of RA.
Wang
Cong-Hua
CH
Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Dai
Jing-Yao
JY
Wang
Li
L
Jia
Jun-Feng
JF
Zheng
Zhao-Hui
ZH
Ding
Jin
J
Chen
Zhi-Nan
ZN
Zhu
Ping
P
D000906:Antibodies / Q000494:pharmacology; D001172:Arthritis, Rheumatoid / Q000201:enzymology* / Q000473:pathology*; D051926:Basigin / Q000378:metabolism*; D002633:Chemotaxis / Q000187:drug effects; D018920:Coculture Techniques; D021984:Cyclophilin A / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D018922:HL-60 Cells; D006801:Humans; D020782:Matrix Metalloproteinases / Q000096:biosynthesis* / Q000235:genetics; D009504:Neutrophils / Q000201:enzymology* / Q000473:pathology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D013582:Synovial Fluid / Q000166:cytology* / Q000187:drug effects
D000906:Antibodies; D012333:RNA, Messenger; D051926:Basigin; D020782:Matrix Metalloproteinases; D021984:Cyclophilin A
Nature. 2003 May 15;423(6937):356-61
12748655
Cell Immunol. 2002 Nov;220(1):20-9
12718936
Rheumatology (Oxford). 2008 Sep;47(9):1299-310
18567920
Scand J Clin Lab Invest Suppl. 1968;97:77-89
4179068
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6360-5
11353871
Arthritis Rheum. 2003 Oct;48(10):2807-18
14558086
Rheumatology (Oxford). 2009 Jul;48(7):721-6
19429906
J Immunol. 2009 Jun 15;182(12):7906-15
19494315
Ann Rheum Dis. 1999 Nov;58(11):691-7
10531073
Arthritis Res Ther. 2006;8(2):R44
16507143
Immunology. 2009 Jan;126(1):55-62
18557953
Arthritis Rheum. 1988 Mar;31(3):315-24
3358796
Cancer Res. 2001 Mar 1;61(5):2276-81
11280798
Am J Pathol. 2001 Aug;159(2):561-70
11485914
Arthritis Rheum. 2000 Feb;43(2):275-80
10693866
Ann Rheum Dis. 1993 Jan;52(1):27-31
8427510
J Biol Chem. 2001 Dec 14;276(50):46870-7
11591720
Ann Rheum Dis. 2002 Nov;61(11):975-80
12379519
Arthritis Res Ther. 2005;7(5):R1023-33
16207318
Proc Natl Acad Sci U S A. 1986 Nov;83(22):8609-13
3464972